Approximately 140 million wounds (acute and chronic) are created annually worldwide that offer potential for use of adjunctive surgical closure and securement products; approximately 42 million of these wounds are created during surgical procedures in the United States.
Although healing of all these wounds might be improved through use of adjunctive surgical closure and securement products, it is likely that increased usage of these products will be limited, on clinical, economic and other grounds, to a fraction of procedures. It is realistically estimated that 10%–15% of these procedures would benefit from increased use of newly developed adjunctive surgical closure and securement products.
The criteria driving which surgical procedures take up adjunctive surgical closure and securement products include clinical utility, cost effectiveness, aesthetic/perceived benefits and others, and (for the sake of understanding) can be grouped into the following categories:
The relative numbers of surgical procedures, grouped by these categories and clinical area, are illustrated below.
Source: MedMarket Diligence, LLC; Report #S190.